Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

RUBY

Rubius Therapeutics (RUBY)

Rubius Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RUBY
DatumZeitQuelleÜberschriftSymbolFirma
10/04/202315h38Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
09/03/202313h33Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:RUBYRubius Therapeutics Inc
03/03/202317h28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
02/03/202314h43Edgar (US Regulatory)Proxy Soliciting Materials (revised) (prer14a)NASDAQ:RUBYRubius Therapeutics Inc
27/02/202314h23Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:RUBYRubius Therapeutics Inc
27/02/202313h37Edgar (US Regulatory)Annual Report (10-k)NASDAQ:RUBYRubius Therapeutics Inc
27/02/202312h52Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
27/02/202312h50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
27/02/202312h49Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:RUBYRubius Therapeutics Inc
22/02/202312h46Edgar (US Regulatory)Withdrawal of Registration Statement (rw)NASDAQ:RUBYRubius Therapeutics Inc
22/02/202312h42Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
09/02/202318h34Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
06/02/202322h06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
20/01/202313h33Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:RUBYRubius Therapeutics Inc
21/12/202223h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
14/12/202222h54Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
12/12/202222h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
02/11/202221h01GlobeNewswire Inc.Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership ChangesNASDAQ:RUBYRubius Therapeutics Inc
13/10/202222h21Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
19/09/202214h00GlobeNewswire Inc.Rubius Therapeutics to Present at Guggenheim Nantucket Therapeutics ConferenceNASDAQ:RUBYRubius Therapeutics Inc
16/09/202206h20TipRanksAnalysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND), Rubius Therapeutics (RUBY) and Connect Biopharma Holdings (CNTB)NASDAQ:RUBYRubius Therapeutics Inc
13/09/202213h17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
13/09/202213h00GlobeNewswire Inc.Rubius Therapeutics Announces Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
12/09/202222h30GlobeNewswire Inc.Rubius Therapeutics to Provide Strategic UpdateNASDAQ:RUBYRubius Therapeutics Inc
09/09/202218h40TipRanksAnalysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Palatin Technologies (PTN) and Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
12/08/202223h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
12/08/202221h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:RUBYRubius Therapeutics Inc
09/08/202218h35TipRanksSVB Securities Keeps Their Hold Rating on Rubius Therapeutics (RUBY)NASDAQ:RUBYRubius Therapeutics Inc
09/08/202214h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:RUBYRubius Therapeutics Inc
09/08/202214h01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:RUBYRubius Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:RUBY